Portland Global Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-33,502
Closed -$2.69M 102
2016
Q4
$2.69M Sell
33,502
-895
-3% -$71K 1.17% 16
2016
Q3
$2.74M Sell
34,397
-535
-2% -$43.2K 1.21% 15
2016
Q2
$2.73M Sell
34,932
-20
-0.1% -$1.43K 1.25% 13
2016
Q1
$1.92M Buy
34,952
+2,340
+7% +$127K 0.92% 28
2015
Q4
$2.01M Buy
32,612
+2,880
+10% +$182K 1.09% 24
2015
Q3
$1.88M Sell
29,732
-240
-0.8% -$17.1K 1.1% 22
2015
Q2
$2.19M Hold
29,972
1.14% 18
2015
Q1
$1.96M Sell
29,972
-390
-1% -$25.9K 1.01% 24
2014
Q4
$1.97M Buy
30,362
+848
+3% +$54.6K 1.02% 24
2014
Q3
$1.77M Sell
29,514
-175
-0.6% -$11.4K 0.92% 28
2014
Q2
$2.06M Sell
29,689
-523
-2% -$33.9K 1.03% 17
2014
Q1
$1.98M Sell
30,212
-1,715
-5% -$112K 1.16% 15
2013
Q4
$1.98M Sell
31,927
-850
-3% -$49.2K 1.23% 16
2013
Q3
$1.76M Sell
32,777
-850
-3% -$43.8K 1.19% 19
2013
Q2
$1.53M Buy
+33,627
New +$1.46M 1.1% 21

Other funds holding STJ

Portland Global Advisors's STJ Position: Q1 2017 in Review

Portland Global Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 33,502 shares — an estimated $2.69M sold.

Portland Global Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $2.74M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Portland Global Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Portland Global Advisors sold 33,502 St Jude Medical shares in Q1 2017, an estimated $2.69M.
  • Portland Global Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Portland Global Advisors's St Jude Medical position peaked at $2.74M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Portland Global Advisors's 13F filing for Q1 2017, filed 18 Apr 2017.